Leukaemia Foundation

Change Your Location:

Leukaemia Foundation presents its Annual Blood Cancer Conference

Publish Date: 23/6/2017

On Saturday 24 June, the Leukaemia Foundation held Sydney’s Annual Blood Cancer Education Conference at Rydges Parramatta, specifically designed for people impacted by a blood cancer diagnosis and their families.

The conference saw leading haematologists, professors, clinicians and researchers come together to provide the latest information on treatments, clinical trials, research developments, living well and survivorship insights, as well as sessions on ten disease specific streams.

Other key note speakers included Australian of the Year 2017, Prof Alan Mackay-Sim who shared his own personal myeloma story, as well as Prof Alan Boddy from Sydney University who discussed cancer therapeutics and personalised medicine.

For the past seven years, the Annual Blood Cancer Education Conference has been the cornerstone of NSW’s education program for people impacted by a blood cancer diagnosis and their families. It is a fundamental part of the Leukaemia Foundation’s commitment to the blood cancer community to provide world-class education and draws upon its strong relationships and connections within the haematological cancer sector.

Presentations from the day

Dr Louella Crawford - The Science and Health of Mind and Spirit

Dr Ibrahim Tohidi-Esfahani Presentation - Waldenstrom's

Prof Alan Boddy - Leukaemia

Prof Ian Kerridge - Myeloma

More information

2017 Sydney Blood Cancer Education Conference (PDF 205kb)

The conference was for everyone affected by lymphoma, non-Hodgkin lymphoma, Hodgkin lymphoma, skin lymphoma, myeloma, multiple myeloma, chronic lymphocytic leukaemia (CLL), chronic myeloid leukaemia (CML), acute lymphoblastic leukaemia (ALL), acute myeloid leukaemia (AML), myelodysplastic syndrome / myelodysplasia (MDS), myeloproliferative Neoplasm (MPN), polycythaemia (PV), myelofibrosis (MF), essential thrombocythaemia (ET), aplastic anaemia (AA), and Waldenstrom’s macroglobulinaemia (WM), and their carers. 

More News